Goldman Sachs GQG Partners International Opportunities Fund Class C (GSILX) is a Foreign Large Growth fund with $53.92 Billion in assets. The fund allocates 37.54% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Novo Nordisk A/S at 5.24% of total assets. This is followed by AstraZeneca PLC (4.75%) and Philip Morris International Inc (6.73%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Novo Nordisk A/S | 5.24% | - | - |
| AstraZeneca PLC | 4.75% | - | - |
| Philip Morris International Inc | 6.73% | - | - |
| NVIDIA Corp | 4.46% | - | - |
| SAP SE | 2.50% | - | - |
| TotalEnergies SE | 2.69% | - | - |
| Taiwan Semiconductor Manufacturing Co Ltd | 2.87% | - | - |
| Nestle SA | 3.14% | - | - |
| Novartis AG | 2.64% | - | - |
| Glencore PLC | 2.52% | - | - |
| Enbridge Inc | 3.28% | - | - |
| Goldman Sachs Financial Square Government Fund | 4.23% | - | - |
| Meta Platforms Inc | 2.56% | - | - |
| British American Tobacco PLC | 4.00% | - | - |
| Chubb Ltd | 2.84% | - | - |
| Iberdrola SA | 2.78% | - | - |